FDA panel votes against broad rollout of Pfizer booster shot, but may endorse narrower use

A Food and Drug Administration advisory panel voted 16-2 Friday to advise the agency against approving a booster dose of the Pfizer-BioNTech Covid-19 vaccine. The vote is non-binding, but it is an unexpected roadblock for the Biden administration’s …

Read more @

Back to top button